Prostemics Co. Ltd (203690) — Capital Reinvestment Ratio
Latest as of December 2021:
5.52x
Prostemics Co. Ltd (203690) has a Capital Reinvestment Ratio of 5.52x as of December 2021, meaning it reinvests 6% of its operating cash flow (₩3.13 Billion) in capital expenditures (₩17.30 Billion). See Prostemics Co. Ltd (203690) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
5.52x
Capex / Operating Cash Flow
Operating Cash Flow
₩3.13 Billion
KRW
Capital Expenditures
₩17.30 Billion
KRW
Data as of
Dec 2021
Most recent filing
Prostemics Co. Ltd Capital Reinvestment Ratio (2015–2021)
This chart tracks Prostemics Co. Ltd's Capital Reinvestment Ratio across 3 annual periods.
Annual Capital Reinvestment Ratio for Prostemics Co. Ltd (2015–2021)
Year-by-year Capital Reinvestment Ratio for Prostemics Co. Ltd from 2015 to 2021. For live market cap and broader valuation context, see how much is Prostemics Co. Ltd worth.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 5.76x | ₩3.00 Billion | ₩17.30 Billion | ▲ +474.9% |
| 2016 | 1.00x | ₩5.86 Billion | ₩5.87 Billion | ▼ -12.1% |
| 2015 | 1.14x | ₩6.25 Billion | ₩7.12 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow